SYNTHESIS, CHARACTERIZATION AND CIEL*a*b* COLOR SPACE STUDY OF TWO ECO-FRIENDLY DIRECT STILBENE AZOIC DYES
Studia Universitatis Babeș-Bolyai Chemia · 25.03.2026 · 19-30
DOI: 10.24193/subbchem.2026.1.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studia Universitatis Babeș-Bolyai Chemia, online erschienen am 25.03.2026. Verfasst von Maria Elena RADULESCU-GRAD und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The article presents the synthesis of two disazo-stilbene dyes with symmetrical structure. A non-carcinogen, non-mutagen/teratogen intermediate, 4,4'-diaminostilben-2,2'-disulfonic acid was used as central component and the 8-amino-1-naphtol-3,6-disulphonic acid and the 6-hydroxynaphthalene-2-sulphonic acid as coupling components respectively. To evaluate the characterization of the dyes, well known and applied methods were used TLC, UV-VIS and FT/IR spectroscopy. Color variations (ΔE*ab and Δh*) were determined relative to a single standard, (C.I.77891 P.W.6). The results highlight a metamerism effect and good coloring properties of the studied dyes.
Zitieren
APA
RADULESCU-GRAD, M. E., POPA, S., BORAN, S., & MOSOARCA, G. (2026). SYNTHESIS, CHARACTERIZATION AND CIEL*a*b* COLOR SPACE STUDY OF TWO ECO-FRIENDLY DIRECT STILBENE AZOIC DYES. Studia Universitatis Babeș-Bolyai Chemia, 19-30. https://doi.org/10.24193/subbchem.2026.1.02
Vancouver
RADULESCU-GRAD ME, POPA S, BORAN S, MOSOARCA G. SYNTHESIS, CHARACTERIZATION AND CIEL*a*b* COLOR SPACE STUDY OF TWO ECO-FRIENDLY DIRECT STILBENE AZOIC DYES. Studia Universitatis Babeș-Bolyai Chemia. 2026:19-30. doi:10.24193/subbchem.2026.1.02
BibTeX
@article{RADULESCUGRAD2026,
author = {RADULESCU-GRAD, Maria Elena and POPA, Simona and BORAN, Sorina and MOSOARCA, Giannin},
title = {SYNTHESIS, CHARACTERIZATION AND CIEL*a*b* COLOR SPACE STUDY OF TWO ECO-FRIENDLY DIRECT STILBENE AZOIC DYES},
journal = {Studia Universitatis Babeș-Bolyai Chemia},
year = {2026},
pages = {19--30},
doi = {10.24193/subbchem.2026.1.02}
}
EUVIMED